Approaching the era of personalised therapy for liver cancer?

Lancet Oncol. 2013 Jan;14(1):7-8. doi: 10.1016/S1470-2045(12)70519-3. Epub 2012 Nov 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / drug therapy*
  • Drug-Related Side Effects and Adverse Reactions*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Pyrrolidinones / administration & dosage*
  • Quinolines / administration & dosage*

Substances

  • ARQ 197
  • Pyrrolidinones
  • Quinolines